Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B4,5 | Lung | Primary cancer | 2,604 | Tumor/Malignant | 73.2% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__87_B4,6 | Lung | Primary cancer | 3,412 | Tumor/Malignant | 75.7% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_B4,7 | Lung | Primary cancer | 3,084 | Immune | 25.8% | 0.49 | 0.80 |
| NSCLC_38242124__IMC__87_B4,9 | Lung | Primary cancer | 391 | Stromal | 44.0% | 0.40 | 0.92 |
| NSCLC_38242124__IMC__87_B5,10 | Lung | Primary cancer | 415 | Stromal | 52.8% | 0.71 | 0.48 |
| NSCLC_38242124__IMC__87_B5,11 | Lung | Primary cancer | 3,545 | Tumor/Malignant | 37.6% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B5,12 | Lung | Primary cancer | 2,494 | Tumor/Malignant | 81.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B5,13 | Lung | Primary cancer | 4,118 | Tumor/Malignant | 27.1% | 0.56 | 0.74 |
| NSCLC_38242124__IMC__87_B5,14 | Lung | Primary cancer | 2,217 | Tumor/Malignant | 58.3% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__87_B5,15 | Lung | Primary cancer | 2,216 | Tumor/Malignant | 27.8% | 0.51 | 0.89 |
| NSCLC_38242124__IMC__87_B5,16 | Lung | Primary cancer | 3,073 | Tumor/Malignant | 39.1% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__87_B5,17 | Lung | Primary cancer | 1,838 | Tumor/Malignant | 41.4% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__87_B5,2 | Lung | Primary cancer | 2,093 | Tumor/Malignant | 39.4% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__87_B5,3 | Lung | Primary cancer | 3,330 | Tumor/Malignant | 50.5% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__87_B5,4 | Lung | Primary cancer | 4,056 | Tumor/Malignant | 69.7% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_B5,5 | Lung | Primary cancer | 4,838 | Tumor/Malignant | 48.3% | 0.87 | 0.36 |
| NSCLC_38242124__IMC__87_B5,6 | Lung | Primary cancer | 2,629 | Tumor/Malignant | 67.2% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__87_B5,7 | Lung | Primary cancer | 5,015 | Tumor/Malignant | 72.6% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B5,8 | Lung | Primary cancer | 3,832 | Tumor/Malignant | 52.9% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B6,1 | Lung | Primary cancer | 3,925 | Tumor/Malignant | 74.5% | 0.99 | 0.03 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B4,5 | Lung | Primary cancer | 2,604 | Tumor/Malignant | 60.9% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__87_B4,6 | Lung | Primary cancer | 3,412 | Tumor/Malignant | 69.6% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_B4,7 | Lung | Primary cancer | 3,084 | Myeloid | 23.1% | 0.37 | 1.04 |
| NSCLC_38242124__IMC__87_B4,9 | Lung | Primary cancer | 391 | Stromal | 44.8% | 0.41 | 0.93 |
| NSCLC_38242124__IMC__87_B5,10 | Lung | Primary cancer | 415 | Stromal | 52.3% | 0.71 | 0.48 |
| NSCLC_38242124__IMC__87_B5,11 | Lung | Primary cancer | 3,545 | Tumor/Malignant | 39.4% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_B5,12 | Lung | Primary cancer | 2,494 | Tumor/Malignant | 81.4% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B5,13 | Lung | Primary cancer | 4,118 | Tumor/Malignant | 27.9% | 0.89 | 0.38 |
| NSCLC_38242124__IMC__87_B5,14 | Lung | Primary cancer | 2,217 | Tumor/Malignant | 51.5% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__87_B5,15 | Lung | Primary cancer | 2,216 | Tumor/Malignant | 23.7% | 0.55 | 0.88 |
| NSCLC_38242124__IMC__87_B5,16 | Lung | Primary cancer | 3,073 | Tumor/Malignant | 39.5% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__87_B5,17 | Lung | Primary cancer | 1,838 | Tumor/Malignant | 22.9% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__87_B5,2 | Lung | Primary cancer | 2,093 | Tumor/Malignant | 31.8% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__87_B5,3 | Lung | Primary cancer | 3,330 | Tumor/Malignant | 34.0% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__87_B5,4 | Lung | Primary cancer | 4,056 | Tumor/Malignant | 69.9% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_B5,5 | Lung | Primary cancer | 4,838 | Tumor/Malignant | 40.1% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__87_B5,6 | Lung | Primary cancer | 2,629 | Tumor/Malignant | 49.6% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_B5,7 | Lung | Primary cancer | 5,015 | Tumor/Malignant | 65.0% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_B5,8 | Lung | Primary cancer | 3,832 | Tumor/Malignant | 53.0% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__87_B6,1 | Lung | Primary cancer | 3,925 | Tumor/Malignant | 78.3% | 0.99 | 0.05 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B4,5 | Lung | Primary cancer | 2,604 | Tumor/Malignant cell | 67.8% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B4,6 | Lung | Primary cancer | 3,412 | Tumor/Malignant cell | 76.9% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B4,7 | Lung | Primary cancer | 3,084 | Other | 24.8% | 0.37 | 1.08 |
| NSCLC_38242124__IMC__87_B4,9 | Lung | Primary cancer | 391 | Fibroblast | 46.0% | 0.29 | 1.05 |
| NSCLC_38242124__IMC__87_B5,10 | Lung | Primary cancer | 415 | Fibroblast | 52.8% | 0.63 | 0.59 |
| NSCLC_38242124__IMC__87_B5,11 | Lung | Primary cancer | 3,545 | Tumor/Malignant cell | 39.6% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__87_B5,12 | Lung | Primary cancer | 2,494 | Tumor/Malignant cell | 79.9% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_B5,13 | Lung | Primary cancer | 4,118 | Tumor/Malignant cell | 40.3% | 0.83 | 0.49 |
| NSCLC_38242124__IMC__87_B5,14 | Lung | Primary cancer | 2,217 | Tumor/Malignant cell | 58.7% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__87_B5,15 | Lung | Primary cancer | 2,216 | Tumor/Malignant cell | 32.9% | 0.88 | 0.44 |
| NSCLC_38242124__IMC__87_B5,16 | Lung | Primary cancer | 3,073 | Tumor/Malignant cell | 43.3% | 0.93 | 0.27 |
| NSCLC_38242124__IMC__87_B5,17 | Lung | Primary cancer | 1,838 | Tumor/Malignant cell | 41.5% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__87_B5,2 | Lung | Primary cancer | 2,093 | Tumor/Malignant cell | 38.6% | 0.91 | 0.29 |
| NSCLC_38242124__IMC__87_B5,3 | Lung | Primary cancer | 3,330 | Tumor/Malignant cell | 49.9% | 0.95 | 0.20 |
| NSCLC_38242124__IMC__87_B5,4 | Lung | Primary cancer | 4,056 | Tumor/Malignant cell | 78.9% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__87_B5,5 | Lung | Primary cancer | 4,838 | Tumor/Malignant cell | 49.6% | 0.86 | 0.40 |
| NSCLC_38242124__IMC__87_B5,6 | Lung | Primary cancer | 2,629 | Tumor/Malignant cell | 67.1% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_B5,7 | Lung | Primary cancer | 5,015 | Tumor/Malignant cell | 79.8% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_B5,8 | Lung | Primary cancer | 3,832 | Tumor/Malignant cell | 70.6% | 0.93 | 0.18 |
| NSCLC_38242124__IMC__87_B6,1 | Lung | Primary cancer | 3,925 | Tumor/Malignant cell | 81.5% | 0.99 | 0.04 |